An experimental HIV prevention pill being developed by Merck could be mass produced for less than $5 per patient a year ...
FDA Commissioner Marty Makary has said the agency needs “giant, big ideas” to counter China’s dominance in early-stage ...
The researchers identified a driving force behind the condition, opening up a potential target for new therapies.
Health care will become autonomous because the survival of health systems depends upon it,” writes former Geisinger CEO Glenn ...
For her new research on the brain’s plumbing system, neuroscientist Maiken Nedergaard had to hone many techniques. Among them ...
People who have been stable for years are suddenly re-exposed to risk — not because their disease worsened, but because their ...
Neurocrine Biosciences is buying Soleno Therapeutics for $2.9 billion, picking up an approved medicine for a rare disease ...
Today's announcement will set the tone for how the Trump administration wants to work with private Medicare insurers.
Companies that sell Medicare Advantage plans will receive a 2.5% pay bump on average in 2027, up significantly from what was ...
A four-month FDA delay prompted a cash-strapped biotech company to shutter. The White House’s proposed NIH cuts are drawing ...
STAT’s Chelsea Cirruzzo and John Wilkerson have the rundown on the proposal, as well as how likely Congress is to go along ...
A bill is moving through the Colorado legislature that would exempt orphan drugs from pricing caps that might be pursued by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results